Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Irradiation Chemotherapy and RT in Anaplastic Astrocytoma
NCT00003621Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 1999
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carmustine, cisplatin and etoposide in anaplastic astrocytoma (AA), sponsored by Cancer and Leukemia Group B. Primary endpoint: Overall Survival up to 10 years. Started Feb 1999; status: completed.
02
Drugs
carmustinecisplatinetoposide
03
Conditions
anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on NCT00003621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003621.